13 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

MACROPORENS CRANILOC

FDA 510(k)
FDA Class 2 ·Neurology

ODYSSEY®

FDA UDI
Microport Orthopedics Inc.·M684K00723341·

ADVANCE®

FDA UDI
Microport Orthopedics Inc.·M684K00273341·

Custom Procedure Kit

FDA UDI
MEDIVATORS INC.·40677964018242·Endo Carry-On Procedure Kit

IMPACT MODULAR TOTAL HIP SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

HITACHI AIRIS II

FDA 510(k)
FDA Class 2 ·Radiology

OT ULTRA METER

FDA Adverse Event
Injury ·LIFESCAN INC.·Product code NBW·September 14, 2011

NEXGEN PROLONG LPS-FLEX ARTICULAR SURFACE

FDA Adverse Event
Malfunction ·ZIMMER·Product code JWH·March 7, 2013

EON MINI IMPLANTABLE PULSE GENERATOR

FDA Adverse Event
Malfunction ·ST. JUDE MEDICAL- NEUROMODULATION·Product code LGW·January 27, 2011

DEEP BRAIN STIMULATION LEAD

FDA Adverse Event
Injury ·MEDTRONIC NEUROMODULATION·Product code MHY·February 22, 2008

Smiths Medical, Medfusion¿ Syringe Infusion Pump, Model 4000, Software Version V1.0 & V1.1, Reorder Numbers 4000-0100-50, 4000-0100-95, 4000-0101-50, 4000-0101-51, and 4000-0101-78. Designed for use in care areas for the administration of fluids requiring precisely controlled infusion rates.

FDA Enforcement
Class I ·Terminated·Smiths Medical ASD, Inc.·August 8, 2012

1202 Flex Focus Ultrasound System, cart models UA1214 and UA1814, used with: Flex Focus 200, Flex Focus 300, Flex Focus 400, Flex Focus 500, Flex Focus 700, Flex Focus 800; System, Imaging, Pulsed Doppler, Ultrasonic

FDA Enforcement
Class II ·Ongoing·B-K Medical A/S·November 12, 2025

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024